Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Altimmune, Inc. - Common Stock (NQ: ALT ) 8.000 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 8.000 Bid (Size) 7.950 (1) Ask (Size) 8.000 (40) Prev. Close 8.000 Today's Range 8.000 - 8.000 52wk Range 5.275 - 14.84 Shares Outstanding 71,124,625 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Mastering Market Chaos: StoryTrading’s Top 5 Stocks You Can’t Ignore December 20, 2024 The trading landscape is alive with opportunity, shaped by a mix of macroeconomic events and sector-specific moves. Via Talk Markets Topics Stocks / Equities Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday December 04, 2024 Via Benzinga Performance YTD -23.95% -23.95% 1 Month -5.10% -5.10% 3 Month +17.47% +17.47% 6 Month +25.29% +25.29% 1 Year -29.52% -29.52% More News Read More 10 Health Care Stocks With Whale Alerts In Today's Session November 13, 2024 Via Benzinga Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday November 12, 2024 Via Benzinga Earnings Scheduled For November 12, 2024 November 12, 2024 Via Benzinga Decoding 4 Analyst Evaluations For Altimmune August 22, 2024 Via Benzinga ALT Stock Earnings: Altimmune Misses EPS for Q2 2024 August 08, 2024 Via InvestorPlace This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday November 12, 2024 Via Benzinga MarketBeat Week in Review – 11/4 - 11/8 November 09, 2024 Via MarketBeat Topics Economy Government Exposures Interest Rates Political How Altimmune Could Grab a Big Chunk of the GLP-1 Market November 08, 2024 Via MarketBeat Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names October 11, 2024 Via Benzinga 1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc) September 17, 2024 Via The Motley Fool 3 Promising Biotech Stocks for the Long-Term: August 2024 August 13, 2024 Via InvestorPlace The 7 Best Under $10 Stocks to Buy in August 2024 August 11, 2024 Via InvestorPlace Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year August 09, 2024 Via The Motley Fool CytoSorbents to Report Second Quarter 2024 Operating and Financial Results August 07, 2024 From CytoSorbents Via GlobeNewswire Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now. August 02, 2024 Via The Motley Fool ALTIMMUNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Altimmune, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm July 30, 2024 From Bragar Eagel & Squire Via GlobeNewswire Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs? July 20, 2024 Via The Motley Fool 3 Undervalued Biotech Stocks With Breakout Potential July 19, 2024 Via InvestorPlace Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio July 17, 2024 Via InvestorPlace Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics July 10, 2024 Via The Motley Fool Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug July 09, 2024 Via MarketBeat 7 Bullish Stock Picks With the Potential to Turn $5K Into $50K July 09, 2024 Via InvestorPlace The 7 Best Under $10 Stocks to Buy in July 2024 July 06, 2024 Via InvestorPlace Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
